Journal | Clinical Prostate Cancer

References: 7, Cited by 3

Clinical Prostate Cancer, Volume 4, pp 134-137; doi:10.3816/cgc.2005.n.023

Early clinical data and potential clinical utility of novel histone deacetylase inhibitors in prostate cancer.

Published: 1 September 2005

Clinical Prostate Cancer, Volume 4

Highlights from the 5th Annual International Congress on Monoclonal Antibodies in Cancer Quebec City, Canada, August 2005; 5th International Prostate Cancer Congress, Rio Grande, Puerto Rico, July 2005; 41st Annual Meeting of the American Society of Clinical Oncology, Orlando, Florida, May 2005.

Published: 1 September 2005

Clinical Prostate Cancer, Volume 4

Potential Role of Inhibiting the Vascular Endothelial Growth Factor Pathway in Advanced Prostate Cancer

Preeta Tyagi, Eric Nadler, Arif Hussain

Published: 1 September 2005

References: 4

Clinical Prostate Cancer, Volume 4, pp 80-82; doi:10.1016/s1540-0352(11)70112-3

Selected Clinical Trials In Prostate Cancer

Published: 1 September 2005

Clinical Prostate Cancer, Volume 4; doi:10.1016/s1540-0352(11)70104-4

Early Clinical Data and Potential Clinical Utility of Novel Histone Deacetylase Inhibitors in Prostate Cancer

G. Kesava Reddy, Eric Nadler, Arif Hussain

Published: 1 September 2005

References: 8, Cited by 1

Clinical Prostate Cancer, Volume 4, pp 83-85; doi:10.1016/s1540-0352(11)70115-9

Recent Trends in Surgical Treatment of Localized Prostate Cancer

Brian A. Link, Daniel J. Culkin

Published: 1 September 2005

References: 30, Cited by 1

Clinical Prostate Cancer, Volume 4, pp 130-133; doi:10.3816/cgc.2005.n.022

Quantitative Computed Tomography Perfusion of Prostate Cancer: Correlation with Whole-Mount Pathology

Elizabeth P. Ives, Melissa A. Burke, Pamela R. Edmonds, Leonard G. Gomella, Ethan J. Halpern

Published: 1 September 2005

References: 24, Cited by 25

Clinical Prostate Cancer, Volume 4, pp 109-112; doi:10.3816/cgc.2005.n.018

A Measure of Health-Related Quality of Life Among Patients with Localized Prostate Cancer: Results from Ongoing Scale Development

Christie A. Befort,

Michael J. Zelefsky

, Peter T. Scardino, Evelinn Borrayo, R. Brian Giesler,

Michael W. Kattan

Published: 1 September 2005

References: 34, Cited by 25

Clinical Prostate Cancer, Volume 4, pp 100-108; doi:10.3816/cgc.2005.n.017

Safety and Tolerability of PCK3145, a Synthetic Peptide Derived from Prostate Secretory Protein 94 (PSP94) in Metastatic Hormone-Refractory Prostate Cancer

Robert E. Hawkins, Luc Daigneault,

Richard Cowan

, Richard Griffiths, Chandra Panchal, Anne Armstrong, Jackie Fenemore, Alan Irvine, Kasia Sereda, Hélène Dulude

Published: 1 September 2005

References: 23, Cited by 8

Clinical Prostate Cancer, Volume 4, pp 91-99; doi:10.3816/cgc.2005.n.016